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PCR-BASED IDENTIFICATION OF Burkholderia pseudomallei
Adam MERRITT, Timothy J.J. INGLIS, Glenys CHIDLOW & Gerry HARNETT
SUMMARY
DNA amplification techniques are being used increasingly in clinical laboratories to confirm the identity of medically important
bacteria. A PCR-based identification method has been in use in our centre for 10 years for Burkholderia pseudomallei and was
used to confirm the identity of bacteria isolated from cases of melioidosis in Ceará since 2003. This particular method has been
used as a reference standard for less discriminatory methods. In this study we evaluated three PCR-based methods of B. pseudomallei
identification and used DNA sequencing to resolve discrepancies between PCR-based results and phenotypic identification methods.
The established semi-nested PCR protocol for B. pseudomallei 16-23s spacer region produced a consistent negative result for one
of our 100 test isolates (BCC #99), but correctly identified all 71 other B. pseudomallei isolates tested. Anomalous sequence
variation was detected at the inner, reverse primer binding site for this method. PCR methods were developed for detection of two
other B. pseudomallei bacterial metabolic genes. The conventional lpxO PCR protocol had a sensitivity of 0.89 and a specificity of
1.00, while a real-time lpxO protocol performed even better with sensitivity and specificity of 1.00, and 1.00. This method
identified all B. pseudomallei isolates including the PCR-negative discrepant isolate. The phaC PCR protocol detected the gene in
all B. pseudomallei and all but three B. cepacia isolates, making this method unsuitable for PCR-based identification of B.
pseudomallei. This experience with PCR-based B. pseudomallei identification methods indicates that single PCR targets should be
used with caution for identification of these bacteria, and need to be interpreted alongside phenotypic and alternative molecular
methods such as gene sequencing.
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INTRODUCTION
The facultative intracellular bacterial pathogen Burkholderia
pseudomallei causes a potentially fatal infection known as melioidosis
which has become established as an endemic disease in north-eastern
Brazil14. The most reliable means of establishing an aetiological
diagnosis is isolation of B. pseudomallei from clinical samples9. Though
this species is easily grown under standard laboratory conditions, it
can be difficult to achieve a definitive identification. Diagnostic
laboratories that regularly encounter B. pseudomallei have found
phenotypic identification methods such as substrate utilisation panels
unreliable for confirmation species identity2,4. Centres such as our own
have come to rely on genotypic methods for identification of B.
pseudomallei. The first such test used for this application was a semi-
nested PCR protocol developed almost a decade ago8. This protocol
enabled assembly of a collection of B. pseudomallei and other
Burkholderia species, benchmarked against type culture collection
strains and imported B. pseudomallei strains from other research
centres. Our Burkholderia Culture Collection has been genotyped by
EcoR1 ribotyping and Xba1 DNA macrorestriction analysis5. The
increasing genetic complexity of the genus Burkholderia made us doubt
the wisdom of relying on a single PCR product to confirm the identity
of new clinical isolates of B. pseudomallei. In a previous study we
therefore evaluated the relative performance of various phenotypic
identification methods, used in conjunction with the established PCR
protocol7. In the present study we sought to compare conventional and
real time PCR identification protocols with the original PCR method
so that we could resolve discrepancies between genotypic and
phenotypic identification methods.
MATERIALS AND METHODS
Bacterial strains: The Burkholderia strains used in this study were
described previously7. Briefly they include 71 B. pseudomallei, 19 B.
cepacia, three B. thailandensis, and one each of B. multivorans and B.
vietnamiensis. In addition, a B. pseudomallei isolate designated NCTC
10276 originating from India was included for phaC sequencing.
Resuscitation: Bacteria were resuscitated by subculture onto 5%
horse blood agar and incubated for 24 h at 37 °C to give single colony
growth. A single blood agar plate was used for each isolate, and stock
cultures were spread to produce single-colony growth in the third or
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fourth quadrant. A single colony was then sub-cultured onto 5% horse
blood agar and incubated at 37 °C for 24 h to produce pure growth for
all subsequent tests.
DNA preparation: A single colony of B. pseudomallei grown on
blood agar (Excel Laboratories, Australia) was re-suspended in
diethylpyrocarbonate treated deionized water. The suspension was heated
at 100 °C for 15 min and centrifuged at 9000 x g to pellet the cell debris.
The supernatant was used as the template for all subsequent PCR assays.
PCR targets, mixes and cycling conditions: All primer design
was conducted using Primer Express software (Applied Biosystems).
Table 1 shows the primer pairs used in this study, their binding site
relative to the start codon of the gene of interest and the annealing
temperature for their respective PCR programs. The Taqman probe
used for realtime detection of lpxO was synthesized by Biosearch
Technologies inc. (Novato, Ca 94949, USA) and consisted of a 5’ 6-
FAM reporter label and a 3’ ‘Black Hole Quencher’. Semi-nested PCR
was performed as described previously7. phaC PCR was performed
using the following PCR mix conditions; 1 unit(u) Amplitaq Gold
Enzyme (Applied Biosystems), PE PCR buffer, 1.5 mM MgCl2, 0.25
mM each dNTP and 0.5 µM of each primer in a total volume of 20 µL
(including 8 µL of template). lpxO PCR was performed using the
following PCR mix conditions; 0.5 u Amplitaq Gold Enzyme (Applied
Biosystems), PE PCR buffer, 2.5 mM MgCl2, 0.2 mM each dNTP and
0.4 µM of each primer in a total volume of 20 µL (including 8 µL of
template). Realtime lpxO PCR was performed using the following PCR
mix conditions; 0.75 u Amplitaq Gold Enzyme (Applied Biosystems),
PE PCR buffer, 4.0 mM MgCl2, 0.2 mM each dNTP and 0.2 µM of
each primer and 0.1 µM of Taqman probe in a total volume of 20 µL
(including 8 µL of template). All other conventional PCR methods
were performed under the following conditions, pre-PCR of 10 minutes
at 95 oC to fully denature the template DNA and activate the polymerase
followed by 45 cycles of 30 sec at 94 oC for denaturation, 30 sec at the
Fig. 1 - Clustal alignment of sequenced 16s-23s spacer PCR first round product for B. pseudomallei NCTC 13177, BCC11 and BCC #99. Arrows indicate annealing sites for the primers used
in the 16s-23s spacer identification assay.
Table 1
Primers and probes used for all PCR
Target Name Primer (5’-3’) Binding site (aa) Annealing temperature (oC)
16s-23s spacer Bp1 CGATGATCGTTGGCGCTT 397* 50
1st round Bp4 CGTTGTGCCGTATTCCAAT 680*
16s-23s spacer Bp1 CGATGATCGTTGGCGCTT 397* 55
2nd round Bp3 ATTAGAGTCGAACAAT 666*
lpxO PCR Sabp76F GCGCCGMTCAATWKKTTCG 112 55
Sabp554R GGCCCARTGCAGSTARGTCTCGT 554
lpxO RealTime Burk-1F TTGTTTCGCCTATGCGTTCTC 123 60
Burk-2R CCACTCGCGCTTGAGGAT 196
Taqman® probe Burk-110 ACGTGCCGAACACGCCGTATATCG 146
phaC Gene1-1108 TGCGGCAGGGGATGAGAA 1108† 55
Gene1-1510 GCAGAAGCCCAGCGTGTTGA 1510†
 * Binding site is numbered using 16s start codon as reference; † binding site is relative to phaC start codon of DSMZ9242 (accession number AF153086)
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appropriate annealing temperature and 45 sec at 72 oC for extension.
Following the final cycle the samples were maintained at 72 oC for a
further seven min. PCR products were demonstrated by Ethidium
bromide gel electrophoresis on 2.5% agar gels. Digital gel images were
captured and optimized for brightness and intensity using UVIdoc
capture system (Cambridge, UK). The lpxO realtime PCR protocol
was performed under the following conditions, pre-PCR of 10 minutes
at 95 oC to fully denature the template DNA and activate the polymerase
followed by 50 cycles of 10 sec at 94 oC for denaturation, 10 sec at the
appropriate annealing temperature and 30 sec at 72 oC for extension.
Amplification and detection was carried out in an Applied Biosystems
Prism 7000 Sequence Detection System.
Sequencing and analysis: Sequencing was carried out on the
products from the first round of semi-nested PCR, lpxO PCR and phaC
PCR in the forward and reverse direction. The PCR products were
treated with pre-sequencing clean-up enzyme (ExoSap-It USB Corp.,
Cleveland, Ohio) and then used as the template in a sequencing mix
(Applied Biosystems, BigDye terminator v3.1). The now labeled
products of the sequencing reaction were then filter purified using
Microcon PCR filters (Amicon Millipore, North Ryde, Australia) and
sequenced in a 3100 Avant genetic analyzer (Applied Biosystems).
Sequences were checked for the presence of ambiguities and
discrepancies between the forward and reverse read using Chromas
v2.3 (Technelysium Pty Ltd, QLD, Australia). Where ambiguities or
discrepancies could not be resolved, the PCR product was re-sequenced
until a clear read was obtained. The sequences were then aligned using
ClustalX v1.8315 and presented in graphic format using Bioedit v7.0.0
(Isis Pharmaceuticals Inc.)3. Lastly, phylogenetic analysis of phaC gene
alignments was conducted using Phylodraw v0.82 (Pusan National
University, South Korea).
RESULTS
16S-23s spacer PCR: In our previous study we reported the
observation that one isolate, (BCC#99) displayed discrepancies between
its phenotype and the results of the semi-nested PCR used as a reference.
In the present study, closer analysis of the semi-nested PCR determined
that no amplification occurred in the second round of amplification,
despite generation of PCR product in the first round. The results of
sequencing the first round product are displayed as a sequence
alignment and shown in Fig. 2. We noted that BCC#99 contained four
nucleotide substitutions and one nucleotide insertion at the binding
site for the reverse primer of the second round PCR (Mong3). With
this one exception, the established 16s-23s spacer PCR method correctly
identified the isolates used in the present study (Table 2).
lpxO conventional PCR & sequencing lpxO realtime PCR: When
we used conventional PCR primers targeting a 900bp B. pseudomallei
homologue of the S. typhimurium lpxO gene to probe our culture
collection, we detected the corresponding PCR product in 64 of 72 B.
pseudomallei isolates and in none of the non-pseudomallei Burkholderia
isolates (Table 2). Sequencing of the lpxO PCR products allowed
adaptation and optimization of the method to real-time PCR which
subsequently identified 72 of 72 B. pseudomallei isolates tested and
resulted in no false positives. The previously PCR-negative discrepant
isolate BCC99 was positive by this method. This assay correctly
identified all B. pseudomallei isolates and excluded near-neighbour
species in approximately 1/3 the time taken by the original semi-nested
method. The semi-nested assay took approximately six hours to
complete, including one hour of technician time. The realtime assay
produced results in two hours with only 30 min of technician time.
Table 2
Results of all PCR assays by species
No. (%) of positive results Total
Species (n) B. pseudomallei (72) B. cepacia (18) B. vietnamiensis (1) B. thailandensis (3) B. multivorans (1) (95)
16s-23s Spacer 71 0 0 0 0 71
lpxO PCR 64 0 0 0 0 64
lpxOTaqman® 72 0 0 0 0 72
phaC PCR 72 15 1 3 1 91
(n) denotes total number of isolates tested for each species.
Fig. 2 - Phylogram of 20 representative Burkholderia spp. including 16 B. pseudomallei
based on DNA sequence of PCR-amplified phaC gene fragments. Other isolates: BCC47 =
B. thailandensis, BCC64 = B. cepacia, BCC65 = B. multivorans and BCC89 = B. vietnamensis.
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phaC PCR and sequencing: The PCR method designed to amplify
a fragment of the phaC gene detected product in all but three of the
isolates tested, none of which were B. pseudomallei (Table 2). The
phaC PCR product was sequenced in 20 distinct strains; 16 B.
pseudomallei and one each of B. thailandensis, B. vietnamiensis, B.
cepacia and B. multivorans. Fig. 2 shows a phylogenetic tree using the
sequences generated. Table 3 shows the percentage identity between
phaC PCR product sequence in the B. pseudomallei isolates and the
other Burkholderia species. Of the 16 B. pseudomallei isolates that
had phaC PCR product sequenced, 10 were indistinguishable and the
remaining six isolates differed by not more than 0.5% from this majority
sequence type. The most closely positioned non-pseudomallei
Burkholderia sp. was B. thailandensis with 94.3% identity to the
majority B. pseudomallei sequence type, followed by B. cepacia, B.
multivorans and B. vietnamiensis.
DISCUSSION
Previous evaluations of B. pseudomallei identification methods have
relied on assumptions about the sensitivity and specificity of the
reference method or the culture collection used to validate the
identification approach taken4,10. In our recent evaluation of
confirmatory phenotypic methods, we regarded the semi-nested PCR
protocol used during assembly of the B. pseudomallei culture collection
as 100% reliable. The isolate known as BCC #99 was therefore classified
according to the results of a B. cepacia PCR-based identification
method, despite the weight of confirmatory phenotypic evidence, which
favored B. pseudomallei7. Discrepancies of this kind need careful
investigation in order to exploit opportunities to improve the
effectiveness of genotypic identification tests. Closer examination of
the PCR-based identification test products indicated that while the PCR
was occurring in the first round of amplification, none occurred in the
second round. When we sequenced the first round PCR product, we
found that nucleotide deletions at the second round reverse primer
binding site produced an aberrant, under-sized first round product and
were sufficient to prevent the primer from annealing. This caused the
false negative PCR result when evaluating the first or second round
products. In view of persuasive confirmatory phenotypic data and the
degree of homology between the remainder of the sequenced PCR
product and an NCTC strain, we believe the definitive identification of
BCC #99 should be changed from B. cepacia to B. pseudomallei.
This newly observed deficiency in the semi-nested method we have
used for six years suggested the need for an alternative PCR-based B.
pseudomallei confirmatory method. As none of the published methods
were ideally suited to the role we previously identified for PCR in our
clinical laboratory B. pseudomallei discovery pathway, we developed
two candidate protocols de novo. Drawing on phenotypic analyses in
which the fatty-acid 2-hydroxymyristate was almost exclusively
produced by B. pseudomallei6, we identified a potential homologue to
a gene used by S. typhimurium in the synthesis of 2HMA1. In the present
study, a real time PCR protocol developed to detect the B. pseudomallei
lpxO homologue correctly distinguished between all tested B.
pseudomallei and non-pseudomallei Burkholderia sp. isolates without
error. The performance of this real time PCR protocol indicates that it
may be a candidate for incorporation in multiplex PCR protocols for
diagnostic and biosecurity applications, subject to more extensive
testing against a larger number of geographically diverse B.
pseudomallei isolates and a wider range of bacteria from other genera.
Sequence variation around the primer binding sites for the B.
pseudomallei lpxO product was minimal, and further adds to the
suitability of the method as a confirmation of identity. But it also
indicates that sequencing of the lpxO PCR product is unlikely to assist
genetic subtyping. However, the product of the phaC PCR method we
developed was more suitable for molecular subtyping for the same
reason.
The polyhydroxybutyrate accumulation pathway is highly
conserved in the Burkholderias. The phaC gene encodes the
polyhydroxybutyrate synthase; the enzyme that polymerizes β-
hydroxybutyrate monomers into PHB12. Using the phaC gene sequence
of Burkholderia species DSMZ9242 (AF153086) as a starting point13,
preliminary alignments of phaC genes from Burkholderia species and
other non-Burkholderias indicated the presence of both conserved and
non-conserved regions, suggesting that it might be a suitable
identification target for attribution of genus and species status. From
our study it is clear that the sequence we chose to amplify is conserved
across a wider range of Burkholderia spp. than B. pseudomallei. The
PCR protocol was therefore unsuited as an aid to species level
identification. However, nucleotide sequence analysis of the phaC PCR
product gave a high level of phylogenetic discrimination between
different Burkholderia species.
The role for PCR-based methods in a B. pseudomallei laboratory
discovery pathway is evident. The real time lpxO PCR protocol is fast
enough to be used for same-day confirmation of presumptive B.
pseudomallei in suitably equipped diagnostic laboratories. Where only
conventional PCR is available, the conventional PCR method is still
fast enough to replace the confirmatory role proposed for gas liquid
chromatography of bacterial fatty acid methyl ester derivatives7. In
the absence of other confirmatory methods; whether phenotypic or
Table 3
Table of percentage identity between studied Burkholderia species of the phaC gene fragment
B. vietnamiensis B. thailandensis B. multivorans B. cepacia
B. pseudomallei* 87.9 94.5 88.8 89.6
B. cepacia 94.5 87.7 93.1
B. multivorans 91.2 97.2
B. thailandensis 86.6
*The majority sequence type was used as the reference sequence for comparison with Burkholderia spp. other than B. pseudomallei.
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genotypic, two complementary PCR-based protocols should be
employed. Despite promising early results from 16S sequencing as a
B. pseudomallei identification method, sequence from the 16s locus
does not always discriminate between B. pseudomallei and other
Burkholderia species. Sequencing of lpxO and other Burkholderia-
specific gene loci may be necessary to resolve equivocal, ambiguous
or otherwise confusing laboratory identification test results. An
increased reliance on molecular methods to confirm the identity of B.
pseudomallei will set the scene for better quality assurance of
presumptive identification tests used in a field setting. Several other
real time PCR protocols have been described for identification of B.
pseudomallei using targets in the 16s rDNA, fliC, and Type Three
Secretion genes15,17,18,19,20. While a study comparing the performance
of these assays has yet to be performed it is likely that one or more
will find a place in an expanded laboratory discovery pathway, possibly
being incorporated into a multiplex real time PCR method.
This investigation of discrepancies between B. pseudomallei PCR-
based and phenotypic identification demonstrated a failure of primer
annealing at the reverse primer binding sites in the original PCR protocol.
Due to the observed failure and relatively long time to result of the 16s-
23s nested method its use was discontinued and a suitable alternative
real-time PCR-based identification protocol targeting a gene locus
specific to B. pseudomallei and associated with bacterial acid fatty acid
metabolism was developed. PCR methods currently incorporated into
B. pseudomallei discovery pathways for use in clinical diagnostic
laboratories should be interpreted alongside other identification tests,
and not relied upon as a stand-alone identification method.
RESUMO
Identificação de Burkholderia pseudomallei baseada em PCR
As técnicas de amplificação de DNA estão sendo cada vez mais
utilizadas em laboratórios clínicos para a confirmação da identificação
de bactérias que têm importância médica. Um método de identificação
de Burkholderia pseudomallei baseado em PCR tem sido usado em nosso
centro há 10 anos e foi utilizado para confirmar a identificação de
bactérias isoladas de casos de melioidose no Ceará desde 2003. Este
método particular tem sido usado como padrão ouro para métodos menos
discriminatórios. Nesse estudo, avaliamos três métodos de identificação
de B. pseudomallei baseados em PCR e usamos seqüenciamento de DNA
para solucionar discrepâncias entre os resultados baseados em PCR e os
métodos de identificação fenotípica. O estabelecido protocolo de PCR
semi-nested para a região espacial 16-23s da B. pseudomallei produziu
um consistente resultado negativo para um de nossos 100 isolados testados
(BCC#99), mas identificou corretamente todos os outros 71 isolados de
B. pseudomallei. Uma variação anômala da seqüência foi detectada na
região interna do sítio de ligação do primer reverso para este método.
Métodos de PCR foram desenvolvidos para a detecção de outros dois
genes bacterianos metabólicos de B. pseudomallei. O protocolo de PCR
IpxO convencional teve sensibilidade de 0,89 e especificidade de 1,0,
enquanto que o PCR em tempo real mostrou-se ainda melhor, com
sensibilidade de 1,0 e especificidade de 1,0. Este método identificou
todos os isolados de B. pseudomallei, incluindo o isolado discrepante
que teve o PCR negativo. O protocolo de PCR phaC detectou o gene de
todos os B. pseudomallei e em todos exceto três isolados de B. cepacia,
tornando este método de identificação de B. pseudomallei baseado em
PCR inadequado. Esta experiência com métodos de identificação de B.
pseudomallei baseados em PCR indica que devemos ter precaução quando
estes forem utilizados sozinhos para identificação dessa bactéria e que
eles necessitam ser interpretados em conjunto com métodos fenotípicos
e moleculares alternativos, tais como seqüenciamento genético.
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